Difficulty: Medium
Average Score: 69%
Practice
A 53-year-old woman with a long history of seizure disorder who has failed therapy with other agents is given a trial of pregabalin. She has a history of partial-onset seizures as well as diabetic peripheral neuropathic pain in both extremities. Which of the following statements is correct about this agent?
Correct answer
A
Rationale
The correct answer is A) Drowsiness and blurred vision would be expected.
Rationale:
Pregabalin is an antiepileptic drug that is also used to treat neuropathic pain. Common side effects of pregabalin include drowsiness and blurred vision. Given the patient's history of partial-onset seizures and diabetic peripheral neuropathic pain, pregabalin is being used to address both conditions. The side effects of drowsiness and blurred vision are anticipated due to the pharmacological actions of pregabalin.
Explanation of why others are wrong:
B) Hepatic excretion will cause jaundice: Pregabalin is primarily excreted renally, not hepatically. Hepatic excretion is not a major route of elimination for pregabalin, so jaundice would not be expected.
C) Her seizures will likely continue: Pregabalin is an antiepileptic drug, so it is intended to help control seizures. It is not accurate to say that her seizures will likely continue if she is being treated with pregabalin.
D) Her neuropathic pain will likely continue: Pregabalin is indicated for the treatment of neuropathic pain, so it is expected to help alleviate her diabetic peripheral neuropathic pain. It is not accurate to say that her neuropathic pain will likely continue if she is being treated with pregabalin.
Educational context:
Understanding the pharmacological properties of drugs is crucial in clinical practice. In this case, knowing the common side effects of pregabalin and its therapeutic uses is essential for healthcare professionals to provide safe and effective care to patients. By selecting the correct answer, healthcare providers can anticipate and manage potential side effects while also addressing the patient's underlying conditions. This case highlights the importance of pharmacological knowledge in individualizing treatment plans for patients with complex medical histories.
Rationale:
Pregabalin is an antiepileptic drug that is also used to treat neuropathic pain. Common side effects of pregabalin include drowsiness and blurred vision. Given the patient's history of partial-onset seizures and diabetic peripheral neuropathic pain, pregabalin is being used to address both conditions. The side effects of drowsiness and blurred vision are anticipated due to the pharmacological actions of pregabalin.
Explanation of why others are wrong:
B) Hepatic excretion will cause jaundice: Pregabalin is primarily excreted renally, not hepatically. Hepatic excretion is not a major route of elimination for pregabalin, so jaundice would not be expected.
C) Her seizures will likely continue: Pregabalin is an antiepileptic drug, so it is intended to help control seizures. It is not accurate to say that her seizures will likely continue if she is being treated with pregabalin.
D) Her neuropathic pain will likely continue: Pregabalin is indicated for the treatment of neuropathic pain, so it is expected to help alleviate her diabetic peripheral neuropathic pain. It is not accurate to say that her neuropathic pain will likely continue if she is being treated with pregabalin.
Educational context:
Understanding the pharmacological properties of drugs is crucial in clinical practice. In this case, knowing the common side effects of pregabalin and its therapeutic uses is essential for healthcare professionals to provide safe and effective care to patients. By selecting the correct answer, healthcare providers can anticipate and manage potential side effects while also addressing the patient's underlying conditions. This case highlights the importance of pharmacological knowledge in individualizing treatment plans for patients with complex medical histories.